Hyperoside induces cell cycle arrest and suppresses tumorigenesis in bladder cancer through the interaction of EGFR-Ras and Fas signaling pathways.

Abstract

Hyperoside is a natural flavonol glycoside widely found in plants and has been reported to have a variety of pharmacological effects, including anticancer abilities. In this study, we demonstrated for the first time that hyperoside inhibited the proliferation of bladder cancer cells in vitro and in vivo. Moreover, hyperoside could not only induce cell cycle arrest, but also induce apoptosis of a few bladder cancer cells. Quantitative proteomics, bioinformatics analysis and Western blotting confirmed that hyperoside induced the overexpression of EGFR, Ras and Fas proteins, which affects a variety of synergistic and antagonistic downstream signaling pathways, including MAPKs and Akt, ultimately contributing to its anticancer effects in bladder cancer cells. This study reveals that hyperoside could be a promising therapeutic strategy for the prevention of bladder cancer.

• Authors: Kai Yang, Zhi-Xiang Qi, Ming-Xin Sun, Li-Ping Xie
• Journal: International journal of medical sciences (Int J Med Sci) Vol. 21 Issue 4 Pg. 690-702 ( 2024) ISSN: 1449-1907 [Electronic] Australia
• PMID: 38464829 (Publication Type: Journal Article)
• Copyright: © The author(s).

Chemical References

• hyperoside
• ErbB Receptors
• EGFR protein, human
• Quercetin

Topics

• Humans
• Signal Transduction
• Cell Cycle Checkpoints
• Urinary Bladder Neoplasms (drug therapy, genetics)
• Apoptosis
• Carcinogenesis (genetics)
• ErbB Receptors (genetics)
• Cell Proliferation
• Cell Line, Tumor
• Quercetin (analogs & derivatives)